000177416 001__ 177416
000177416 005__ 20240229133739.0
000177416 0247_ $$2doi$$a10.3390/cancers13215407
000177416 0247_ $$2pmid$$apmid:34771570
000177416 0247_ $$2altmetric$$aaltmetric:116576618
000177416 037__ $$aDKFZ-2021-02508
000177416 041__ $$aEnglish
000177416 082__ $$a610
000177416 1001_ $$00000-0003-4357-0567$$ade Villiers, Ethel-Michele$$b0$$eFirst author
000177416 245__ $$aBovine Meat and Milk Factors (BMMFs): Their Proposed Role in Common Human Cancers and Type 2 Diabetes Mellitus.
000177416 260__ $$aBasel$$bMDPI$$c2021
000177416 3367_ $$2DRIVER$$aarticle
000177416 3367_ $$2DataCite$$aOutput Types/Journal article
000177416 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1637075805_5623$$xReview Article
000177416 3367_ $$2BibTeX$$aARTICLE
000177416 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000177416 3367_ $$00$$2EndNote$$aJournal Article
000177416 500__ $$a#EA:F200#LA:F200#
000177416 520__ $$aExemplified by infections with bovine meat and milk factors (BMMFs), this manuscript emphasizes the different mechanistic aspects of infectious agents contributing to human cancers by 'direct' or 'indirect' interactions. The epidemiology of cancers linked to direct carcinogens (e.g., response to immunosuppression) differs from those cancers linked with indirect infectious interactions. Cancers induced by direct infectious carcinogens commonly increase under immunosuppression, whereas the cancer risk by indirect carcinogens is reduced. This influences their responses to preventive and therapeutic interferences. In addition, we discuss their role in colon, breast and prostate cancers and type II diabetes mellitus. A brief discussion covers the potential role of BMMF infections in acute myeloid leukemia.
000177416 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000177416 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000177416 650_7 $$2Other$$abovine meat and milk factors (BMMF)
000177416 650_7 $$2Other$$achronic zoonosis
000177416 650_7 $$2Other$$aindirect carcinogenesis
000177416 7001_ $$0P:(DE-He78)3f43953e63fd34eca1891c5a0d9d344c$$azur Hausen, Harald$$b1$$eLast author$$udkfz
000177416 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers13215407$$gVol. 13, no. 21, p. 5407 -$$n21$$p5407$$tCancers$$v13$$x2072-6694$$y2021
000177416 909CO $$ooai:inrepo02.dkfz.de:177416$$pVDB
000177416 9101_ $$0I:(DE-588b)2036810-0$$60000-0003-4357-0567$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000177416 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3f43953e63fd34eca1891c5a0d9d344c$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000177416 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000177416 9141_ $$y2021
000177416 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2019$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-05-04
000177416 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2019$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000177416 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000177416 9201_ $$0I:(DE-He78)F200-20160331$$kF200$$lF200 Arbeitsgruppe Episomal-Persistierende DNA in Krebs- und chron. Erkrankungen$$x0
000177416 980__ $$ajournal
000177416 980__ $$aVDB
000177416 980__ $$aI:(DE-He78)F200-20160331
000177416 980__ $$aUNRESTRICTED